Management of hypertension in relation to acute coronary syndromes and revascularisation

Area of Science:

• Cardiology
• Hypertension Research
• Acute Coronary Syndromes

Background:

• Hypertension is a frequent comorbidity in patients presenting with acute coronary syndromes (ACS).
• The interplay between hypertension and ACS necessitates tailored treatment algorithms based on ACS type and hypertension severity.
• Understanding myocardial perfusion in hypertensive patients is key to managing these conditions.

Purpose of the Study:

• To review the prevalence of hypertension and ACS as distinct and combined clinical entities.
• To explore the pathophysiology of myocardial perfusion in hypertensive individuals and the impact of blood pressure normalization.
• To analyze treatment strategies for hypertension in ACS from both non-interventional and interventional viewpoints.

Main Methods:

• Literature review focusing on the combined presentation of hypertension and ACS.
• Discussion of pathophysiology related to myocardial perfusion and blood pressure management.
• Comparative analysis of therapeutic drugs for hypertension in ACS, examining their mechanisms and prognostic implications.

Main Results:

• Treatment algorithms for ACS are influenced by hypertension severity and ACS type (e.g., ST-elevation myocardial infarction vs. malignant hypertension).
• Simultaneous treatment of both conditions is often required, with revascularization considered after initial ACS management.
• Optimized hypertension control can prevent future complications.

Conclusions:

• Integrated management of hypertension and ACS is essential for optimal patient outcomes.
• A comprehensive understanding of pharmacological and interventional options is vital for treating hypertensive patients with ACS.
• Personalized treatment strategies considering both ACS and hypertension are critical for preventing adverse events.